SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-028731
Filing Date
2024-04-01
Accepted
2024-04-01 16:06:16
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202772-10k_china.htm   iXBRL 10-K 1218502
2 THE FIRST AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY ea020277201ex3-2_china.htm EX-3.2 6246
3 THE SECOND AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY ea020277201ex3-3_china.htm EX-3.3 5260
4 LOAN SETTLEMENT AGREEMENT BETWEEN CHINA PHARMA HOLDINGS, INC. AND MS. ZHILIN LI ea020277201ex10-13_china.htm EX-10.13 19818
5 TECHNOLOGY TRANSFER AGREEMENT BETWEEN HAINAN HELPSON MEDICAL & BIOTECHNOLOGY CO. ea020277201ex10-14_china.htm EX-10.14 30225
6 TECHNOLOGY TRANSFER AGREEMENT BETWEEN HAINAN HELPSON MEDICAL & BIOTECHNOLOGY CO. ea020277201ex10-15_china.htm EX-10.15 29166
7 OFFICE LEASE FOR SECOND FLOOR OF THE COMPANY'S PRINCIPAL EXECUTIVE OFFICE DATED ea020277201ex10-16_china.htm EX-10.16 62920
8 OFFICE LEASE FOR THIRD FLOOR OF THE COMPANY'S PRINCIPAL EXECUTIVE OFFICE DATED J ea020277201ex10-17_china.htm EX-10.17 61789
9 CONSENT OF THE INDEPENDENT ACCOUNTING FIRM. ea020277201ex23-1_china.htm EX-23.1 1823
10 CERTIFICATION ea020277201ex31-1_china.htm EX-31.1 10596
11 CERTIFICATION ea020277201ex31-2_china.htm EX-31.2 10991
12 CERTIFICATION ea020277201ex32-1_china.htm EX-32.1 6071
13 COMPENSATION RECOVERY POLICY OF THE COMPANY ea020277201ex97-1_china.htm EX-97.1 32169
14 GRAPHIC image_001.jpg GRAPHIC 14136
15 GRAPHIC ex3-2_001.jpg GRAPHIC 149625
16 GRAPHIC ex3-2_002.jpg GRAPHIC 299591
17 GRAPHIC ex3-2_003.jpg GRAPHIC 221590
18 GRAPHIC ex3-2_004.jpg GRAPHIC 266999
19 GRAPHIC ex3-2_005.jpg GRAPHIC 53493
20 GRAPHIC ex3-2_006.jpg GRAPHIC 286051
21 GRAPHIC ex3-2_007.jpg GRAPHIC 213133
22 GRAPHIC ex3-2_008.jpg GRAPHIC 200869
23 GRAPHIC ex3-3_001.jpg GRAPHIC 139001
24 GRAPHIC ex3-3_002.jpg GRAPHIC 152606
25 GRAPHIC ex3-3_003.jpg GRAPHIC 306922
26 GRAPHIC ex3-3_004.jpg GRAPHIC 219963
27 GRAPHIC ex3-3_005.jpg GRAPHIC 289053
28 GRAPHIC ex3-3_006.jpg GRAPHIC 284578
29 GRAPHIC ex3-3_007.jpg GRAPHIC 188289
  Complete submission text file 0001213900-24-028731.txt   10639976

Data Files

Seq Description Document Type Size
30 XBRL SCHEMA FILE cphi-20231231.xsd EX-101.SCH 49221
31 XBRL CALCULATION FILE cphi-20231231_cal.xml EX-101.CAL 50497
32 XBRL DEFINITION FILE cphi-20231231_def.xml EX-101.DEF 268908
33 XBRL LABEL FILE cphi-20231231_lab.xml EX-101.LAB 465937
34 XBRL PRESENTATION FILE cphi-20231231_pre.xml EX-101.PRE 260580
102 EXTRACTED XBRL INSTANCE DOCUMENT ea0202772-10k_china_htm.xml XML 499258
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34471 | Film No.: 24809157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)